Skip to main content
iwCLL 2025 Main banner
Final Program


iwCLL X / Twitter

Poster

1404 - A Phase 2 study with Tafasitamab and Zanubrutinib in newly diagnosed chronic lymphocytic leukemia/small lymphocytic lymphoma – TaZa CLL Study

    Primary Author / Presenter(s)

  • GP

    Georgios Pongas, MD

    Assistant Professor of Medicine
    University of Miami, Sylvester Comprehensive Cancer Center
    Miami, Florida,USA, Florida, United States

    • Co-Author(s)

  • MM

    Matthew Mei, MD

    City of Hope National Medical Center
    Duarte, California, United States

  • LC

    Lu Chen, PhD

    City of Hope National Medical Center
    Duarte, California, United States

  • GS

    Geoffrey Shouse, DO

    City of Hope National Medical Center
    Duarte, California, United States

  • DS

    D. Lynne Smith, PhD

    Sr Project Development Scientist
    City of Hope National Medical Center
    Duarte, California, United States

  • RB

    Rachel Bellsmith

    City of Hope National Medical Center
    Duarte, California, United States

  • IB

    Ivana Borja

    City of Hope National Medical Center
    Duarte, California, United States

  • SR

    Steven T. Rosen, MD

    Provost & Chief Scientific Officer
    Toni Stephenson Lymphoma Center, Beckman Research Institute,City of Hope
    Duarte, California, United States

  • Tanya Siddiqi, MD

    Professor
    City of Hope Orange County
    Irvine, California, United States

  • Alexey V. Danilov, MD, PhD

    Professor
    Department of Hematology and Transplantation, City of Hope National Medical Center
    Duarte, California, United States